Literature DB >> 15566308

New constrained "molecular tongs" designed to dissociate HIV-1 protease dimer.

Naïma Merabet1, Julien Dumond, Bruno Collinet, Laurence Van Baelinghem, Nicole Boggetto, Sandrine Ongeri, Fariza Ressad, Michèle Reboud-Ravaux, Sames Sicsic.   

Abstract

New "molecular tongs" based on naphthalene and quinoline scaffolds linked to two peptidic strands were synthesized. They were designed to prevent dimerization of HIV-1 protease by targeting the antiparallel beta-sheet involving N- and C-termini of each monomer. Compared to "molecular tongs" previously described (Bouras, A.; Boggetto, N.; Benatalah, Z.; de Rosny, E.; Sicsic, S.; Reboux-Ravaud, M. J. Med. Chem. 1999, 42, 957-962), two main different structural features were introduced: positively charged quinoline as a new scaffold and two peptidic strands displaying different sequences. Seventeen new "molecular tongs" with dipeptidic or tripeptidic strands were synthesized. These molecules were assayed on HIV-1 protease using the Zhang kinetic technique. Eleven molecules behaved as pure dimerization inhibitors, mostly at the submicromolar range. Compared to a naphthalene scaffold, the quinoline one was shown in several cases to favor dimerization inhibition. The simplified hydrophobic Val-Leu-Val-OMe strand was confirmed as particularly favorable. The C-terminal analogue strand Thr-Leu-Asn-OMe was shown to be the best one for inducing dimerization inhibition (K(id) of 80 nM for compound 30). The mechanism of inhibition was ascertained using ANS binding and gel filtration. Experimental results are in agreement with the dissociation of the HIV-1 protease dimeric form in the presence of the synthesized molecular tongs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15566308     DOI: 10.1021/jm040833q

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Dimerization of Bacterial Diaminopimelate Decarboxylase Is Essential for Catalysis.

Authors:  Martin G Peverelli; Tatiana P Soares da Costa; Nigel Kirby; Matthew A Perugini
Journal:  J Biol Chem       Date:  2016-02-26       Impact factor: 5.157

2.  Targeting human immunodeficiency virus type 1 assembly, maturation and budding.

Authors:  Johanna Wapling; Seema Srivastava; Miranda Shehu-Xhilaga; Gilda Tachedjian
Journal:  Drug Target Insights       Date:  2007-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.